CytoSorbents Archives

Press ESC key to close search

Bridge Bank Provides $5MM Debt Financing to CytoSorbents

CytoSorbents received $5 million in non-dilutive debt financing under the terms of the fourth amendment to its amended and restated loan and security agreement with Bridge Bank.

Bridge Bank Provides New $15MM Term Loan to CytoSorbents

Bridge Bank provided a new $15 million term loan for CytoSorbents Corporation after the company repaid the outstanding principal balance of its existing $15 million term loan with the bank.

December 14, 2020 Bridge Bank | CytoSorbents | Kathleen P. Bloch | Lindsay Fouty Phil Neuffer

Bridge Bank Provides $15MM Facility to CytoSorbents

CytoSorbents, a critical care immunotherapy leader specializing in blood purification, refinanced its existing $10 million term loan with a new $15 million debt facility with Bridge Bank.

April 5, 2018 Bridge Bank | CytoSorbents | Justin McDonie ABF Journal

Bridge Bank Provides $10MM of Debt Financing to CytoSorbents

CytoSorbents closed on a $10 million senior debt facility with the Life Sciences group of Bridge Bank.

July 5, 2016 Bridge Bank | CytoSorbents ABF Journal

<img width="200" src="https://www.abfjournal.com/wp-content/uploads/2020/02/abfj-logo-web-header1-blue.png" alt="ABFJournal" />

Tag Archives: CytoSorbents

Bridge Bank Provides $5MM Debt Financing to CytoSorbents

Bridge Bank Provides New $15MM Term Loan to CytoSorbents

Bridge Bank Provides $15MM Facility to CytoSorbents

Bridge Bank Provides $10MM of Debt Financing to CytoSorbents